The TACTT team focuses on developing novel, targeted anticancer strategies that specifically eliminate tumor cells and mostly leave normal, healthy cells alone. Targeted therapy is a cancer treatment that uses drugs to target specific genes and proteins that are involved in the growth and survival of cancer cells. We are convinced that precision medicine using rationally-designed combinations of such targeted therapies may achieve this much-needed progress in cancer treatment. Moreover, we focus on oxygen deficiency (hypoxia) as a common characteristic of human solid tumours contributing to therapy resistance.

Team Leader

Prof. Dr. An Wouters

Associated promotors (alphabetically)

Prof. Dr. Christophe Deben
Prof. em. Dr. Martin Lammens
Prof. Dr. Filip Lardon
Prof. em. Dr. Patrick Pauwels
Prof. Dr. Marc Peeters
Prof. Dr. Evelien Smits
Prof. em. Dr. Jan B. Vermorken

Postdoctoral researchers

Dr. Jorrit De Waele

PhD students

Stephanie Jordaens
Jöran Melis
Jasper Verswyvel
Hannah Zaryouh


Christophe Hermans
Hilde Lambrechts
Céline Merlin